HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.0
  1. Home
  2. /Compound

Leuprolide Acetate

HCID 657180
New noteNew reactionRequest quotes
Print preview
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
74381-53-6
Standard SMILES
CC(=O)O.CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1
InChIKey
RGLRXNKKBLIBQS-XNHQSDQCSA-N
Molecular formula
C61H88N16O14
Average molar mass
1,269.4 g/mol
Monoisotopic mass
1,268.66659154

Overview

Leuprolide Acetate can cause developmental toxicity, female reproductive toxicity and male reproductive toxicity according to state or federal government labeling requirements.

Names & identifiers

Preferred name
Leuprolide Acetate
IUPAC
acetic acid;(2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-5-(diaminomethylideneamino)-1-[(2S)-2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide
English name
Leuprorelin acetate
Molecular formula
C61H88N16O14
Molecular weight
1269.45

Names & synonyms

Leuprolide acetateLeuprorelin acetate74381-53-6LupronLucrinCarcinilEnantoneLeuplinTrenantoneEligardProstapViadur
Show more names
LEUPROLIDELeuprolide acetate (Leuprorelin acetate)6-D-Leucine-9-(N-ethyl-L-prolinamide)-10-deglycinamideluteinizing Hormone-Releasing Factor Acetate(Pig)TPA-144DC-2-269
Lupron DepotAbbott-43818FensolviLupanetaProcrinTAP-144Lutrate depotUno-Enantone

Database identifiers

CAS
74381-53-6
PubChem CID
657180
DTXSID
DTXSID7049009
ChEMBL

Properties

Computed structural properties

Topological polar surface area
469 Ų
Hydrogen bond donors
16
Hydrogen bond acceptors
16
Rotatable bonds
32
Heavy atoms
91
Formal charge
0
Complexity
2,420

Experimental & physicochemical properties

Human Drugs · 2 items

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Physicochemical properties

Melting point
150 · 150-155°C
storage temp.
-20 °C · -20°C
solubility
DMSO (Slightly), Methanol (Slightly)
form
Solid
color
White to Off-White
Merck
14 · 14,5457
InChIKey
RGLRXNKKBLIBQS-XNHQSDQCSA-N
NCI Dictionary of Cancer Terms
leuprolide acetate; Lupron
FDA UNII
37 JNS02E7V · 37JNS02E7V
NCI Drug Dictionary
leuprolide acetate
Proposition 65 List
Leuprolide Acetate
UNSPSC Code
12352200 · 12352200
NACRES
32 · NA.32

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 4 items

Danger

H317 (30.6%): May cause an allergic skin reaction [Warning Sensitization, Skin]

P203, P233, P260, P261, P271, P272, P280, P284, P302+P352, P304+P340, P317, P318, P321, P333+P317, P342+P316, P362+P364, P403, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 62 reports by companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Hazard information

Regulatory InformationHazard Traits - Developmental Toxicity; Reproductive Toxicity
Hazard Classes and CategoriesSkin Sens. 1 (30.6%)

Toxicology

Drug Induced Liver Injury · 6 items

Drug Induced Liver Injury Rank (DILIrank 2.0)

Leuprolide acetate

vLess-DILI-concern

3

Adverse reactions

DOI:10.1016/j.drudis.2016.02.015

Safety data

PPE
Eyeshields, Gloves, type N95 (US)
wgk
2
rtecs
OH6390000
hs_code
29371900
Signal word
Warning
Symbol(GHS)
GHS07
safety_code
22-24/25
Storage Class

Chemistry & industry

Pharmacology

FDA Pharmacological Classification · 2 items

LEUPROLIDE ACETATE

Gonadotropin Releasing Hormone Receptor Agonist [EPC]; Gonadotropin Releasing Hormone Receptor Agonists [MoA]

MeSH Pharmacological Classification · 2 items

Compounds which increase the capacity to conceive in females.

Antineoplastic agents that are used to treat hormone-sensitive tumors. Hormone-sensitive tumors may be hormone-dependent, hormone-responsive, or both. A hormone-dependent tumor regresses on removal of the hormonal stimulus, by surgery or pharmacological block. Hormone-responsive tumors may regress when pharmacologic amounts of hormones are administered regardless of whether previous signs of hormone sensitivity were observed. The major hormone-responsive cancers include carcinomas of the breast, prostate, and endometrium; lymphomas; and certain leukemias. (From AMA Drug Evaluations Annual 1994, p2079)

Uses & manufacturing

UsesUse (kg) in USA (2002): 1
Applications · 4 items

DescriptionLeuprolide acetate is a potent analog of LH-RH useful in achieving a medical castration in the treatment of advanced prostate cancer. It has also been investigated for the treatment of advanced breast cancer.

UsesLeuprolide acetate USP (Leupron) is used to treat Prostatic carcinoma.

UsesSynthetic nonapeptide agonist analog of LH-RH. Antineoplastic (hormonal).

UsesIn mice, leuprolide acetate salt has been used to check the need of estrogen receptor α in spermatogenic cells, for development or function in fertilization.

Upstream & downstream products

Related reactions

0 records
New reaction record

No reaction records under the current filter.

Compound notes

Loading…

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
More actions
New noteNew reactionRequest quotes
CHEMBL1200775
ChEBI
CHEBI:63597
UNII
37JNS02E7V
EC Number
686-285-8
Protein binding
43 · 43-49%
Excreted unchanged in urine
5 · <5 (+ metabolites)
Volume of distribution
27 Litres · 27 Litres
Biological half-life
3 · 3 / increased
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
315 · H315
Precautionary statements
264 · P264-P280-P302+P352-P332+P313-P362+P364
PPE
95 · Eyeshields, Gloves, type N95 (US)
Safety Statements
22 · 22-24/25
WGK Germany
2 · 2
RTECS
6390000 · OH6390000
HS Code
29371900 · 29371900
Storage Class
11 · 11 - Combustible Solids
11 - Combustible Solids
Hazard statements
H315
Precautionary statements
P264-P280-P302+P352-P332+P313-P362+P364

Upstream raw materials

Dicyclohexylcarbodiimidehydrogen fluorideBoc-Tyr(2,6-di-Cl-Bzl)-OHBoc-D-Ser(Bzl)-OHBOC-L-LeucineBoc-Arg(Tos)-OHN-[(tert-Butoxy)carbonyl]-L-tryptophanBOC-D-Leucine monohydrateBoc-His(Dnp)-OH
Additional notes · 1 item

DefinitionChEBI: An acetate salt obtained by combining the nonapeptide leuprolide with acetic acid. A long lasting GnRH analog, LH-Rh agonist. It is a synthetic nonapeptide analogue of gonadotropin-releasing hormone, and is used as a subcutaneous hydrogel implant for the t eatment of prostate cancer and for the suppression of gonadal sex hormone production in children with central precocious puberty.